Financing type:  bought deal prospectus offering

Gross proceeds:  $11,500,092

Offering:  22,549,200 listed shares with 11,274,600 warrants

Offering price:  51 cents per unit

Warrant exercise terms:  60 cents per listed share until July 14, 2028

Overallotment option:  The underwriters may purchase a maximum of 2,941,200 units for overallotment purposes. As of July 14, 2026, such option has been fully exercised. All information presented herein includes such exercise.

Commissions in securities:  647,076 broker warrants (three brokers)

Broker warrant terms:  Each broker warrant is non-transferable and exercisable into one broker unit at 51 cents for a period of 18 months from the date of issuance. Each broker unit comprises one listed share and one-half warrant. Each whole warrant is exercisable at an exercise price of 60 cents until July 14, 2028.

Disclosure:  Refer to the prospectus dated July 9, 2026, and the company's news releases dated July 7, 2026, and July 14, 2026.